Characteristics of high–drug-cost beneficiaries of public drug plans in 9 Canadian provinces: a cross-sectional analysis
M Tadrous, D Martins, MM Mamdani… - … Association Open Access …, 2020 - cmajopen.ca
Background: Drugs are the fastest growing cost in the Canadian health care system, owing
to the increasing number of high-cost drugs. The objective of this study was to examine the …
to the increasing number of high-cost drugs. The objective of this study was to examine the …
Comparison of claims from high–drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis
Background: Globally, payers are struggling with rising drug costs, driven primarily by the
increasing number of high-cost medications used by their beneficiaries. We aimed to …
increasing number of high-cost medications used by their beneficiaries. We aimed to …
[HTML][HTML] Difference in drug cost between private and public drug plans in Quebec, Canada
M Chamoun, A Forget, I Chabot, M Schnitzer… - BMC Health Services …, 2022 - Springer
Background We expect a difference in drug cost between private drug plans and the Public
Drug Plan (PDP) because the dispensing fee is fixed and regulated by the PDP for publicly …
Drug Plan (PDP) because the dispensing fee is fixed and regulated by the PDP for publicly …
Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures
V Demers, M Melo, C Jackevicius, J Cox… - Cmaj, 2008 - Can Med Assoc
Background: Reimbursement for outpatient prescription drugs is not mandated by the
Canada Health Act or any other federal legislation. Provincial governments independently …
Canada Health Act or any other federal legislation. Provincial governments independently …
[HTML][HTML] Financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey data
L McLeod, BG Bereza, M Shim, P Grootendorst - Open Medicine, 2011 - ncbi.nlm.nih.gov
Background Commentaries on the adequacy of insurance coverage for prescription drugs
available to Canadians have emphasized differences in the coverage provided by different …
available to Canadians have emphasized differences in the coverage provided by different …
The impact of the introduction of a formulary into a large Canadian private drug plan: an interrupted time-series analysis
A Cassels, MR Law - Canadian Medical Association Open Access …, 2019 - cmajopen.ca
Background: Most private drug plans in Canada do not use a formulary, which leads to
suboptimal drug use. We studied the impact of the adoption of the public formulary by a …
suboptimal drug use. We studied the impact of the adoption of the public formulary by a …
Prescribed Drug Spending in Canada, 2019: A Focus on Public Drug Programs.
K Lee, T Jani, R Cheng, J Hunt - Healthcare Quarterly (toronto, Ont.), 2020 - europepmc.org
Prescribed Drug Spending in Canada, 2019: A Focus on Public Drug Programs. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
[HTML][HTML] Addressing cost-related barriers to prescription drug use in Canada
Drug formularies Provincial and territorial governments in Canada have a direct influence on
the provision of prescription drugs by establishing drug formularies, negotiating drug prices …
the provision of prescription drugs by establishing drug formularies, negotiating drug prices …
[HTML][HTML] The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey
MR Law, L Cheng, A Kolhatkar, LJ Goldsmith… - … Open Access Journal, 2018 - cmajopen.ca
Background: Many Canadians face substantial out-of-pocket charges for prescription drugs.
Prior work suggests that this causes some patients to not take their medications as …
Prior work suggests that this causes some patients to not take their medications as …
Cost-effectiveness of the top 100 drugs by public spending in Canada, 2015–2021: a repeated cross-sectional study
É Gaudette, S Rizzardo, Y Zhang, KR Pothier… - BMJ open, 2024 - bmjopen.bmj.com
Objectives To assess the distribution and spending by cost-effectiveness category among
those drugs with the highest public spending levels in Canada. Design Repeated cross …
those drugs with the highest public spending levels in Canada. Design Repeated cross …
